New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA team of researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATA
World medicine December 07,2023
Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA team of researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATA
World medicine December 07,2023
CBD shows promise for fighting aggressive brain cancer

CBD shows promise for fighting aggressive brain cancer

by Experimental BiologyThe researchers believe that CBD's anti-cancer actions target mitochondria -- the cell's energy producing structures -- by causing the mitochondria to dysfunction and re
World medicine December 07,2023
CBD shows promise for fighting aggressive brain cancer

CBD shows promise for fighting aggressive brain cancer

by Experimental BiologyThe researchers believe that CBD's anti-cancer actions target mitochondria -- the cell's energy producing structures -- by causing the mitochondria to dysfunction and re
World medicine December 07,2023
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

byFred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainPatients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vac
World medicine December 07,2023
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

byFred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainPatients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vac
World medicine December 07,2023
National kidney cancer study shows promising results

National kidney cancer study shows promising results

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainUC Davis Comprehensive Cancer Center has taken part in testing the anti-cancer drug everolimus as part of a phase III clinical trial t
World medicine December 07,2023
National kidney cancer study shows promising results

National kidney cancer study shows promising results

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainUC Davis Comprehensive Cancer Center has taken part in testing the anti-cancer drug everolimus as part of a phase III clinical trial t
World medicine December 07,2023
Annual Report to the Nation part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

Annual Report to the Nation part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

byNational Cancer InstituteLung cancer diagnoses fell from March 2020 to May 2020, one of six major cancer types to experience a dip during the early part of the pandemic. Credit: National Cance
World medicine December 07,2023
Annual Report to the Nation part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

Annual Report to the Nation part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

byNational Cancer InstituteLung cancer diagnoses fell from March 2020 to May 2020, one of six major cancer types to experience a dip during the early part of the pandemic. Credit: National Cance
World medicine December 07,2023
International Prognostic Scoring System-Molecular changes clinical management

International Prognostic Scoring System-Molecular changes clinical management

by Lori SolomonImplementing the International Prognostic Scoring System-Molecular (IPSS-M) in clinical practice could impact clinical management for nearly half of patients with myelodysplastic syndro
World medicine December 07,2023
International Prognostic Scoring System-Molecular changes clinical management

International Prognostic Scoring System-Molecular changes clinical management

by Lori SolomonImplementing the International Prognostic Scoring System-Molecular (IPSS-M) in clinical practice could impact clinical management for nearly half of patients with myelodysplastic syndro
World medicine December 07,2023
International study identifies new breast cancer susceptibility genes

International study identifies new breast cancer susceptibility genes

byLaval UniversityCredit: Pixabay/CC0 Public DomainA large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the Univ
World medicine December 07,2023
International study identifies new breast cancer susceptibility genes

International study identifies new breast cancer susceptibility genes

byLaval UniversityCredit: Pixabay/CC0 Public DomainA large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the Univ
World medicine December 07,2023
What to know about supplements and cancer

What to know about supplements and cancer

by Susanna Fraser, Huntsman Cancer InstituteCredit: Pixabay/CC0 Public DomainFrom vitamin A capsules to herbal teas and zinc tablets, dietary supplements come in all shapes and sizes. But are they a g
World medicine December 07,2023
What to know about supplements and cancer

What to know about supplements and cancer

by Susanna Fraser, Huntsman Cancer InstituteCredit: Pixabay/CC0 Public DomainFrom vitamin A capsules to herbal teas and zinc tablets, dietary supplements come in all shapes and sizes. But are they a g
World medicine December 07,2023
Curettage and cryosurgery found to be effective for the most common skin cancer

Curettage and cryosurgery found to be effective for the most common skin cancer

byUniversity of GothenburgSuperficial basal cell carcinoma. Credit: Wikimedia Commons, CC0 1.0The number of cases of skin cancer is continuing to rise sharply, in Sweden and internationally, inv
World medicine December 07,2023
Curettage and cryosurgery found to be effective for the most common skin cancer

Curettage and cryosurgery found to be effective for the most common skin cancer

byUniversity of GothenburgSuperficial basal cell carcinoma. Credit: Wikimedia Commons, CC0 1.0The number of cases of skin cancer is continuing to rise sharply, in Sweden and internationally, inv
World medicine December 07,2023
Death rates from prostate cancer predicted to decline overall in EU but rise in Poland

Death rates from prostate cancer predicted to decline overall in EU but rise in Poland

byEuropean Society for Medical OncologyBar-plots of age-standardized death rates per 100,000 people a year in 2015 and predicted rates in 2020 for all cancers and 10 major cancer sites in EU men
World medicine December 07,2023
Death rates from prostate cancer predicted to decline overall in EU but rise in Poland

Death rates from prostate cancer predicted to decline overall in EU but rise in Poland

byEuropean Society for Medical OncologyBar-plots of age-standardized death rates per 100,000 people a year in 2015 and predicted rates in 2020 for all cancers and 10 major cancer sites in EU men
World medicine December 07,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com